Immunomedics, Inc. (NASDAQ: IMMU) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that the FDA has accepted its Biologics License Agreement, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about: The acceptance of the Biologics License … Read more
Immunomedics, Inc. (NASDAQ: IMMU) is having a great start to the trading session this morning, and for good reason. The company provided a comprehensive overview of clinical development at the 2018 ASCO Annual Meeting. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about: The … Read more
Immunomedics, Inc. (NASDAQ: IMMU) is having an overwhelmingly strong day in the market, and for good reason. The company made a key business update that led to excitement among investors. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:59), IMMU is trading at $6.79 … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics was having a relatively normal day in the market today. After starting the day in the green, the stock dipped a bit, then traded on the day relatively flat. While there was some movement, it definitely wasn’t worth writing home about. That is, until minutes ago when the stock spiked … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics is having an incredibly strong day in the market today. In fact, when the market opened, the stock was already trading well into the green. However, since then, there has been no signs of slowing gains as the stock continues to rocket upward. Below, we’ll talk about what we’re seeing … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics is having an overwhelmingly strong day in the market today. Since the opening bell rang just minutes ago, the stock has been in the green. When it rang, the stock hit the ground running, skyrocketing toward the top. Below, we’ll talk about what we’re seeing from the stock, why, and … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics is having an incredibly rough time in the market today, and for good reason. The company was expected to give a presentation at the ASCO, however, the presentation had been canceled. Today, we’ll talk about the news, how the market reacted to the news, and what we can expect to … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics is having an incredible day in the market today and for very good reason. The company recently received word from the FDA with regard to an investigational antibody drug conjugate it has been working on known as sacituzumab govitecan (IMMU-132). Today, we’ll talk about the news from the FDA, how … Read more
MannKind Corporation Is Up: Is There Room Left For More Gains? MannKind Corporation (NASDAQ: MNKD) MannKind is having an incredible day in the market today. As market turmoil starts to subside, the stock is climbing; currently it’s (2:15) trading at $4.00 per share after a gain of 3.09% so far. While we’re likely to see … Read more
Immunomedics, Inc. (NASDAQ: IMMU) Immunomedics is having a great day in the market today after announcing results from a phase 2 study that looked into the effectiveness of the company’s lead investigational antibody drug. Today, we’ll take a look at the data from the phase 2 study, talk about how the market reacted, and discuss … Read more